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Abstract
Sentinel lymph node (SLN) biopsy has increasingly become important in axillary staging of breast 
cancer patients since SLN biopsy alleviates the postoperative complications of previously 
practiced axillary lymph node dissections. Nevertheless, the procedures of SLN biopsy using blue 
dye and radioactive substance are still intraoperative, and the latter methods are also ionizing. In 
this pilot study, we have proposed noninvasive in vivo spectroscopic photoacoustic (PA) SLN 
mapping using gold nanorods as lymph node tracers in a rat model. Gold nanorods have 
biocompatibility, high optical absorption, and easily tuned surface plasmon resonance peak 
wavelength.
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Introduction
Sentinel lymph node biopsy (SLNB) has become an axillary staging routine for breast 
cancer patients as an alternative to traditional axillary lymph node dissection (ALND) [1]. 
Sentinel lymph nodes (SLNs) are defined as the first draining lymph nodes. Metastatic 
cancer cells tend to orderly progress out of the original cancer site through the SLNs [1, 2]. 
In ALND, ten or more lymph nodes are resected. By contrast, in SLNB, only the SLNs are 
biopsied to determine whether further lymph node dissection is necessary or not [3]. If the 
SLNs are cancer-free, the chances are low that the other lymph nodes are affected; thus, no 
more lymph node dissection is necessary. SLNB has become a standard procedure in 
axillary staging because it has less invasiveness and side effects than ALND. Furthermore, 
ALND does not improve the survival rate in comparison to SLNB while causing significant 
morbidity, such as lymphedema, limitations of arm and shoulder movement, and numbness 
in the upper arm.
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In SLNB, blue dye (methylene blue or isosulfan blue) and radioactive isotope materials 
(99mTc) are administered near the cancer five minutes and 24 hours before a surgery, 
respectively [2–4]. The injected tracers flow to the SLNs via the lymphatic system. The 
accumulated blue dye is visually detected through the surgery, while radioactive substances 
are detected by a Geiger counter [5]. Since blue dye molecules are small and can easily 
migrate to adjacent lymph nodes passing the SLNs, the blue dye based method alone may 
have a high false positive rate [6, 7]. Because radioactive isotope materials are bigger (~500 
nm), the method using these substances is expected to have less migration to echelon lymph 
nodes. However, those bigger colloids are mostly retained in the interstitial space and 
significantly less accumulated in the lymph nodes.[1] Moreover, this method not only has 
poor spatial resolution, making SLN mapping difficult, but also uses harmful ionizing 
radioactive materials, which cause damage on connective tissues and also require a special 
facility to produce.
These complications initiated studies to find safe, noninvasive, and high-resolution SLN 
mapping methods, avoiding invasive surgeries and allowing minimally invasive staging by 
such as needle biopsy. Optical imaging is one of such methods because it is safe and non-
ionizing. Further, it is more sensitive to imaging contrast than other conventional imaging 
methods, such as magnetic resonance imaging (MRI), X-ray computed tomography (X-ray 
CT), and positron emission tomography (PET). Therefore, near-infrared fluorescent type II 
quantum dots have been used as optical lymph node tracers and successfully applied to map 
SLNs in an animal model [8]. However, because of strong light scattering, this kind of 
purely optical imaging techniques based on diffuse light detections suffer from poor spatial 
resolution beyond the quasi-diffusive regime [9]. To overcome the poor spatial resolution, 
hybrid imaging modalities such as photoacoustic (PA) imaging, have been implemented by 
detecting ultrasound instead of light [10]. In PA imaging, a short pulsed laser illuminates 
biological tissue. Optical absorbers in the tissue absorb optical energy and expand because 
of thermo-elastic expansion, generating ultrasonic waves. As a result, PA imaging inherits 
high optical contrast and excellent ultrasonic spatial resolution. Because PA imaging uses 
multiply scattered photons, it has fairly deep imaging depth while maintaining satisfactory 
spatial resolution [10, 11]. The modality has been successfully employed to image various 
biological structures of small animals [10, 12] and also extended to clinical studies [13].
In this study, we have successfully mapped a SLN using spectroscopic photoacoustic 
imaging using gold nanorods in a rat model. Similar to other metal nanoparticles, gold 
nanorods have 5 orders of magnitude higher molar optical absorption than conventional 
absorbing dye molecules [14]. In addition, the surface plasmon resonance (SPR) peak 
wavelength of nanorods can be easily tuned because that depends on the shape, mainly on 
the aspect ratio of the axial diameter to the longitudinal length [14]. We showed that the gold 
nanorods can be used as new lymph node tracers. In addition, to identify the SLN out of 
blood vessels without taking a control image before the injection of tracers, we have 
proposed a spectroscopic PA mapping method.
Song et al. Page 2
Eur J Radiol. Author manuscript; available in PMC 2020 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Materials and Methods
A. Photoacoustic imaging system
The PA imaging system is schematically described in Fig. 1A. The system was designed to 
image deeply located biological structures [10]. For PA excitation, a Ti:sapphire laser 
(LT-2211A, LOTIS TII) pumped by a Q-switched Nd:YAG (LS-2137/2, LOTIS TII) laser 
was employed. The laser system has a 10 Hz pulse repetition rate and about 10 ns pulse 
width. The laser beam with high optical energy was delivered to an object through two 
prisms and three optical parts. The three optical parts—a concave lens, a spherical conical 
lens, and an optical condenser—were employed to form ring-shaped illumination. Such 
dark-field illumination reduces unwanted surface PA signal generation, which otherwise 
overshadows PA signals generated from a deep region [10]. For spectroscopic PA imaging, 
wavelengths of 757 nm, 807 nm, and 820 nm from the tunable Ti:sapphire laser were 
chosen. The laser beam was sufficiently broadened to satisfy the ANSI safety limit (actual 
fluence: 6.9 mJ/cm2, limit: 31 mJ/cm2) [15].
For raster scanning, a motorized XY linear translation stage (XY-6060, Danaher Motion) 
was used, which was controlled by a computer. For Z directional (depth) adjustment of the 
scan head, another linear translation stage (KR-20, THK) was employed. Scanning stepsizes 
for a 1-D scan (X direction) and for a 2-D scan (XY directions) were 0.2 mm and 0.4 mm, 
respectively. With the current laser system, the total acquisition time for a 25 mm × 30 mm 
field of view was 23 min.
Three-dimensional data was acquired by the raster scanning (Fig. 1B). At a given point, a 
time-resolved PA signal was received by an ultrasonic transducer (Fig. 1Ba). This PA signal 
was then converted to a depth-resolved signal by multiplying the time by the speed of sound 
(Fig. 1Bb). The depth-resolved PA signal is called an A-scan, which is a 1-D image. Once 
multiple A-scans are acquired with 1-D scanning (X direction), a B-scan (2-D image) was 
obtained (Fig. 1Bc). Similarly, multiple B-scans compose a 3-D image with another 1-D 
scanning (Y direction). Although the 3-D image can be viewed in various forms, it is here 
expressed in the form of maximum amplitude projection (MAP), which projects the 
maximum of each A-scan onto the corresponding XY coordinate.
For PA signal detection, a 5 MHz central frequency ultrasonic transducer (V308, 
Panametrics-NDT) was used, which has a 2.54 cm focal length, a 1.91 cm aperture, and a 
72% nominal bandwidth at full width at half maximum (FWHM). With the transducer, the 
axial resolution and the transverse resolution at 19 mm deep were about 144 μm and 560 
μm, respectively [10]. The resolutions were experimentally measured by imaging human 
hairs in scattering medium. The transducer mechanically scanned an object in a water 
container through a bottom opening (5 cm × 5 cm), which was sealed with a thin and clear 
membrane. The object was placed below the water container. To couple ultrasound between 
the transducer and the object, ultrasonic gel (Sonotec Inc.) was applied between the object 
and the membrane. Received PA signals were amplified by an amplifier (5072PR, 
Panametrics-NDT), digitized by an oscilloscope (TDS 5054, Tektronix), and then stored in 
the computer. Since the laser system has pulse-to-pulse fluctuations in energy, the PA signals 
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were corrected by signals from a photodiode, which measures the energy of the original 
laser beam.
B. Animal and drug information.
Adult male Sprague Dawley rats weighing ~400 g were used. Before depilation in the 
axillary region, a mixture of ketamine (85 mg/kg) and xylazine (15 mg/kg) was administered 
in a rat. After the hair removal, the rat was put sideway on an animal holder. During all 
image acquisitions, the rat was kept under anesthesia with a vaporized-isoflurane system (1 
L/min oxygen and 0.75% isoflurane, Euthanex Corp.) while the vitals were monitored by a 
pulse oximeter (NONIN Medical INC., 8600V). For hydration, 1 ml of 0.9% saline was 
subcutaneously administered between image acquisitions.
As lymph node tracers, gold nanorods (Nanopartz Inc.) were injected on a left forepaw pad 
in the amount of 0.1 ml at a 979-pM concentration.[16] The gold nanorods used for this 
study have a 10 nm diameter, a 41 nm length, and an 807 nm SPR peak wavelength. Figure 2 
shows the shape and the absorbance spectrum of gold nanorods used for this study. After 
data acquisition, the animal was euthanized by a pentobarbital overdose. All animal 
experiments were carried out in compliance with the guidelines on the care and the use of 
laboratory animals from Washington University in St. Louis.
RESULTS
Noninvasive in vivo PA SLN mapping with gold nanorods has been successfully 
accomplished in a rat model. An axillary region of a rat shown in Fig. 3A was scanned with 
the PA imaging system. Fig. 3B is an anatomical photograph taken after all image 
acquisitions, with the skin and surrounding fatty tissue removed, revealing a SLN. Insets are 
photographs of a top view and a bottom view of the dissected SLN, in which the nanorod-
accumulated parts are in red color. Before the injection of the gold nanorods, a PA image 
was acquired as a control to be compared with images taken after the injection. The control 
image was then processed to form a saggital MAP image (Fig. 3D). The vasculature of the 
axilla was clearly imaged with good contrast. After the injection of the gold nanorods on the 
left forepaw pad of the rat, we obtained consecutive PA images until the SLN appears clearly 
in the image. Fig. 3E is a saggital PA MAP image acquired 1.5 hours after the injection, 
where no SLN is visible. At 19 hours after the injection, the SLN was barely seen with a low 
contrast (Fig. 3F). At 46 hours after the injection, the SLN was clearly imaged with good 
contrast (Fig. 3G). One of the B-scans (Fig. 3C) acquired at the dotted line in Fig. 3G 
provides depth information of the SLN and the blood vessels. The average depth of the 
SLNs of rats weighing ~400 g is about 1.5 mm from the skin surface. In the B-scan image, 
the skin surface is not seen clearly because the high contrast signal of the SLN suppresses 
the low contrast signal of the skin.
If the above method were used to identify a SLN, a control image has to be acquired before 
the injection, and then an after-injection image was compared with the control image. 
However, if the technique is to be extended to the clinic, it is inconvenient to acquire a 
control image. In addition, if we do not have prior information about the vascular 
morphology in an axillary region, we cannot separate the SLN out of blood vessels. 
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Therefore, a spectroscopic PA method using 757 nm, 807 nm, and 820 nm wavelengths was 
applied to identify the SLN, avoiding the need of acquiring a control image. Fig. 4A shows 
the changes of the PA amplitudes versus the wavelengths in the SLN and the blood vessel. 
As expected, the PA amplitudes (squares with dotted lines) obtained from the SLN reach the 
maximum at the 807 nm wavelength, which is the SPR peak wavelength of the gold 
nanorods. The PA amplitudes follow the absorbance curve of the gold nanorods (Fig. 2). By 
contrast, the PA amplitudes (circles with solid lines) acquired from the blood vessel (dotted 
box in Fig. 3G) follow the absorption coefficient curve of 70% oxygenated hemoglobin in 
veins (Fig. 4B) [17]. Circles in Fig. 4B indicate the wavelengths used for the spectroscopic 
PA imaging.
Discussion
We demonstrated the feasibility of noninvasive in vivo PA SLN mapping by injecting gold 
nanorods into rats. In a lymphatic system, it is well known that smaller sized nanoparticles 
(<5 nm) migrate to SLNs faster than larger nanoparticles [5]. Methylene blue, which has a 
0.7 nm in diameter and a 1.6 nm in length [6], takes 5 minutes to reach SLNs in humans. 
Radioactive isotope,99mTc (~1000 nm), takes up to 24 hours. Spherical nanoparticles of 40 
nm in diameter take about 4.6 minutes to reach SLNs of rats [18]. Here, we observed that the 
gold nanorods with a 10 nm diameter and a 41 nm length took more than 20 hours to reach 
the SLNs. The reticuloendothelial cells might react differently to nanoparticles of different 
shapes. Further biological study will be needed to understand this phenomenon. Another 
aspect affecting the accumulation time is the surface condition of the nanorods for the 
lymphatic system. The nanorods used for this study are plain nanoparticles, so phagocytosis 
occurs actively in extracellular space, and hence slower drainage. PEGylation can improve 
the drainage rate of nanoparticles since this process changes the surface condition of the 
nanorods from hydrophobic to hydrophilic, resulting in less phagocytosis in extracellular 
space [19] and aggregation at the injection site [20].
The nanoparticles injected into the body are removed by reticuloendothelial systems, such as 
monocytes and macrophages. In addition, their long term toxicity is still studied in various 
research groups. To reduce any potential toxicity, it is recommended to minimize the dosage 
of nanoparticles. In this study, the minimum dosage detectable by the PA system was 
estimated based on the acquired images. Since the detection limit of the system is about 
10dB and the SNR of the SLN is about 34dB, the dosage can be roughly reduced by a factor 
of 15.
We have also proposed the spectroscopic method to separate SLNs out of blood vessels 
without obtaining a control image. As seen in Fig. 4A, the SLN could be separated from the 
blood vessel because the optical absorption spectra of both nanorods and hemoglobin have 
different profiles. Although the PA amplitude variations at the three wavelengths are small 
because of the small wavelength difference between the selected wavelengths compared to 
the broad spectrum of the nanorods, the profile of the nanorods (squares with the dotted 
lines) is distinct from the profile of the vein (circles with the solid lines). In the blood vessel, 
which is labeled vein in Fig. 4A, the spectral profile does not follow the one of the gold 
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nanorods, but follow the absorption spectrum of 70% oxygenated hemoglobin in a vein. 
Thus, this blood vessel is considered to be a venous blood vessel.
Owing to the wavelength-dependent optical attenuation in the skin, the optical fluence 
reaching the SLNs is also wavelength-dependent. This effect on the SLN region should be 
corrected to produce accurate spectra of PA amplitudes. In this study, we compensated the 
PA signals using the diffusion equation with experimentally measured effective attenuation 
coefficients of the rat skin. To measure the effective attenuation coefficients, a highly 
absorptive object (a carbon rod) with an absorption coefficient independent of the 
wavelength was inserted below the skin of a rat. PA signals were then measured over 
multiple wavelengths [21]. The PA signals are proportional to specific optical absorption at 
the carbon rod, which reflects the relative spectral dependence of the optical fluence.
Since the imaging system employs a single ultrasonic transducer and the pulse repetition rate 
of the laser system is limited to 10 Hz, the total acquisition time for a 25 mm × 30 mm field 
of view was 20 seconds and 23 minutes for 2-D (B-scan) and 3-D imaging, respectively. 
Artifacts due to breathing motions were unavoidable. If we employ an ultrasonic array 
system and a faster pulse-repetition-rate laser system, the breathing motion effect can be 
minimized. A breathe-gating system will also be able to reduce the motion artifact. These 
systems can also reduce the amplitude variations of PA signals between image acquisitions, 
possibly caused by breathing motion (focal zone effect) and physiological variations 
(concentration and oxygenation of hemoglobin) of the animal.
In summary, noninvasive PA SLN mapping using gold nanorods has been successfully 
accomplished. Gold nanorods possess several orders of magnitude higher molar optical 
absorption than conventional dye, and their optical absorption peak wavelength can be easily 
tuned to the spectral window of low optical attenuation in tissue by changing the aspect 
ratio. In addition, gold material is biocompatible. We demonstrated that gold nanorods can 
be good optical lymph node tracers. To make the PA SLN mapping more practical, we have 
also proposed a spectroscopic method. With this method, we could identify the SLN out of 
blood vessels. The proposed spectroscopic mapping method can potentially be extended to 
the clinic with the aid of a faster acquisition system.
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Figure 1. 
(A) Schematic of a deeply penetrating reflection-mode photoacoustic imaging system. (B) 
Image formation. A-scan: 1-D image and B-Scan: 2-D image. A B-scan is composed of 
multiple A-scans. Multiple B-scans form a 3-D image. PA: Photoacoustic.
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Figure 2. 
Absorbance of gold nanorods. Diameter: 10 nm, length: 41 nm, and a SPR peak wavelength: 
807 nm. Normalized values are presented. Circles represent the wavelengths used for 
spectroscopic photoacoustic SLN mapping. Inset is a TEM image of the gold nanorods
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Figure 3. 
A saggital photoacoustic MAP image of the axilla, showing the vasculature and sentinel 
lymph node. (A) Photograph of the region of interest with hair removed before imaging. (B) 
Anatomical photograph of the axilla with skin and fatty tissue removed. Sentinel lymph 
node is indicated by an arrow. Insets are a top view and a bottom view of the dissected 
sentinel lymph node, respectively. (C) B-scan acquired at the dotted line in Fig. 3(G). (D) 
Photoacoustic MAP image acquired before the injection, showing the axillary vasculature. 
(E) Photoacoustic MAP image taken 1.5 hours after the injection. (F) Photoacoustic MAP 
image acquired at 19 hours after the injection. (G). Photoacoustic MAP image acquired at 46 
hours after the injection. The sentinel lymph node appears slightly in Fig. 3F and strongly in 
Fig. 3G.
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Figure. 4. 
(A) Photoacoustic amplitude versus the wavelengths from the nanorods (sentinel lymph 
node) and the venous vessel. Squares with dotted lines indicate the PA signals from the 
nanorods. Circles with solid lines represent the PA signals from the venous vessel. Errorbar 
represents standard error. (B) Absorption coefficient of 70% oxygenated hemoglobin in 
venous vessel. Circles indicate the wavelengths used for the spectroscopic measurement.
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